3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
2
Lymphoma
2
Triple Negative Breast Neoplasms
1
Neuroblastoma
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
Glioblastoma
1
Ganglioneuroblastoma
1
Burkitt Lymphoma
1
Astrocytoma
1
Interventions
pembrolizumab
55
Carboplatin
55
Pemetrexed
47
Cisplatin
37
Paclitaxel
21
Nivolumab
20
Docetaxel
19
durvalumab
18
osimertinib
14
Gemcitabine
14
Cetuximab
14
130-nm albumin-bound paclitaxel
14
atezolizumab
12
Specimen Handling
12
Magnetic Resonance Spectroscopy
12
amivantamab
10
Radiotherapy
8
lazertinib
7
Taxes
7
Radiosurgery
7
alectinib
6
Ramucirumab
6
Observation
6
Ipilimumab
6
Bevacizumab
6
cemiplimab
5
Leucovorin
5
Fluorouracil
5
zimberelimab
4
entrectinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Non-Small-Cell Lung
×
Leukapheresis
×
30 days
×
Clear all
No trials found.